Takeda Pharmaceutical
307 hedge funds and large institutions have $1.98B invested in Takeda Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 100 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
13% less call options, than puts
Call options by funds: $57.8M | Put options by funds: $66.4M
25% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 100
Holders
307
Holding in Top 10
7
Calls
$57.8M
Puts
$66.4M
Top Buyers
| 1 | +$33.1M | |
| 2 | +$16.1M | |
| 3 | +$8.42M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.59M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.24M |
Top Sellers
| 1 | -$67.4M | |
| 2 | -$31.5M | |
| 3 | -$20.4M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$15.1M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$11.3M |